Damora Therapeutics, Inc. · NASDAQ:DMRA
Jarrett Jennifer bought 12,500 Damora Therapeutics, Inc. shares (Form 4)
Traded Sep 25, 2026 · Filed Sep 28, 2026
On Sep 25, 2026, Jarrett Jennifer (Director, Director, President and CEO) bought 12,500 Damora Therapeutics, Inc. shares at US$20.23 for US$253K, leaving 512,500 shares. Filed Sep 28, 2026 (Form 4).
- Bought
- 12,500 shares
- Price
- US$20.23
- Value
- US$253K
- Holding after
- 512,500 shares
- Trading plan
- No
- Role
- Director, Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Ordinary Shares | Buy | 12,500 | US$20.23 | 512,500 | Direct |
Source
Related
- Damora Therapeutics, Inc.
- Jarrett Jennifer
- Damora Therapeutics, Inc. shareholders
- Form 4 · Jarrett Jennifer · Apr 1, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026